These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31782880)

  • 21. Relationships of elevated systemic pentraxin-3 levels with high-risk coronary plaque components and impaired myocardial perfusion after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction.
    Kimura S; Inagaki H; Haraguchi G; Sugiyama T; Miyazaki T; Hatano Y; Yoshikawa S; Ashikaga T; Isobe M
    Circ J; 2014; 78(1):159-69. PubMed ID: 24132243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
    Nishiguchi T; Tanaka A; Taruya A; Emori H; Ozaki Y; Orii M; Shiono Y; Shimamura K; Kameyama T; Yamano T; Yamaguchi T; Matsuo Y; Ino Y; Kubo T; Hozumi T; Hayashi Y; Akasaka T
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2460-2467. PubMed ID: 27687605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentraxin Level is the Key to Determine Primary Percutaneous Coronary Intervention (PCI) or Fibrinolysis.
    Haybar H; Parsa SA; Khaheshi I; Zayeri ZD
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(2):160-168. PubMed ID: 30465517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention.
    Dogdus M; Yenercag M; Ozyasar M; Yilmaz A; Can LH; Kultursay H
    Angiology; 2021 Mar; 72(3):221-227. PubMed ID: 32996338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
    Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
    Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of residual intrastent thrombus during primary angioplasty: insights from the COCTAIL II study.
    Gatto L; Romagnoli E; Versaci F; Limbruno U; Pawlowski T; Porto I; Marco V; Di Vito L; Imola F; Cremonesi A; Prati F
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):348-353. PubMed ID: 28212135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients Presenting with Acute Myocardial Infarction.
    Alkhalil M; Kearney A; Hegarty M; Stewart C; Devlin P; Owens CG; Spence MS
    Am J Med; 2019 Dec; 132(12):e827-e834. PubMed ID: 31152721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels of inflammatory parameters pentraxin-3, cyclophilin and heparin-binding epidermal growth factor-like growth factor in patients with ST-elevation myocardial infarction.
    Vuković Dejanović V; Bogavac-Stanojević N; Kotur Stevuljević J; Vukašinović A; Stefanović A; Kafedzic S; Zdravković M; Ilić I; Hinić S; Cerović M; Stefanović M; Spasojević-Kalimanovska V; Memon L; Nešković AN
    Scand J Clin Lab Invest; 2020 Feb; 80(1):66-72. PubMed ID: 31799884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of thrombus aspiration on postprocedural outcomes in elderly patients with acute ST-elevation myocardial ınfarction.
    Emre E; Ural E; Kahraman G; Bildirici U; Kilic T; Bozyel S; Onuk R; Akbulut T; Ural D
    Geriatr Gerontol Int; 2016 Jun; 16(6):722-8. PubMed ID: 26246152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
    Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
    BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
    Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
    Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Previously diagnosed cancer and mortality after ST-segment elevation acute myocardial infarction treated with primary angioplasty.
    Iglesias-Garriz I; Delgado I; Prieto-Salvador I; Garrote C; García-Palomo A; Fernández-Vazquez F
    Catheter Cardiovasc Interv; 2020 Jun; 95(7):1269-1274. PubMed ID: 31584247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Tasar O; Karabay AK; Oduncu V; Kirma C
    Coron Artery Dis; 2019 Jun; 30(4):270-276. PubMed ID: 31026233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a combination of antiplatelet and antithrombotic pretreatment on myocardial perfusion in patients with an acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Prech M; Bartela E; Janus M; Jeremicz I; Araszkiewicz A; Urbanska L; Pyda M; Grajek S
    Coron Artery Dis; 2016 Nov; 27(7):580-5. PubMed ID: 27228184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiographic characteristics and in-hospital mortality among patients with ST-segment elevation myocardial infarction presenting without typical chest pain: an analysis of China Acute Myocardial Infarction registry.
    Song CX; Fu R; Yang JG; Xu HY; Gao XJ; Wang CY; Zheng Y; Jia SB; Dou KF; Yang YJ;
    Chin Med J (Engl); 2019 Oct; 132(19):2286-2291. PubMed ID: 31567475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 9p21 Rs 1333040 polymorphism is associated with coronary microvascular obstruction in ST-segment elevation myocardial infarction treated by primary angioplasty.
    Fracassi F; Niccoli G; Vetrugno V; Cauteruccio M; Buffon A; Gatto I; Giarretta I; Tondi P; Pola R; Crea F
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):703-707. PubMed ID: 28984467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
    Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
    van Diepen S; Alemayehu WG; Zheng Y; Theroux P; Newby LK; Mahaffey KW; Granger CB; Armstrong PW
    J Thromb Thrombolysis; 2016 Oct; 42(3):376-85. PubMed ID: 27324144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.